MRES (Institute of Biomedical Research) Asset Turnover: 0.00 (As of Dec. 2010)


What is Institute of Biomedical Research Asset Turnover?

Institute of Biomedical Research MRES Asset Turnover is 0.00 as of Dec. 2010.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Institute of Biomedical Research's Revenue for the three months ended in Dec. 2010 was $0.00 Mil. Institute of Biomedical Research's Total Assets for the quarter that ended in Dec. 2010 was $0.66 Mil. Therefore, Institute of Biomedical Research's Asset Turnover for the quarter that ended in Dec. 2010 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Institute of Biomedical Research's annualized ROE % for the quarter that ended in Dec. 2010 was 56.49%. It is also linked to ROA % through Du Pont Formula. Institute of Biomedical Research's annualized ROA % for the quarter that ended in Dec. 2010 was -33.86%.

Institute of Biomedical Research  (OTCPK:MRES) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Institute of Biomedical Research's annulized ROE % for the quarter that ended in Dec. 2010 is

ROE %**(Q: Dec. 2010 )
=Net Income/Total Stockholders Equity
=-0.224/-0.3965
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.224 / 0)*(0 / 0.6615)*(0.6615/ -0.3965)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*-1.6683
=ROA %*Equity Multiplier
=-33.86 %*-1.6683
=56.49 %

Note: The Net Income data used here is four times the quarterly (Dec. 2010) net income data. The Revenue data used here is four times the quarterly (Dec. 2010) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Institute of Biomedical Research's annulized ROA % for the quarter that ended in Dec. 2010 is

ROA %(Q: Dec. 2010 )
=Net Income/Total Assets
=-0.224/0.6615
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.224 / 0)*(0 / 0.6615)
=Net Margin %*Asset Turnover
= %*0
=-33.86 %

Note: The Net Income data used here is four times the quarterly (Dec. 2010) net income data. The Revenue data used here is four times the quarterly (Dec. 2010) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Institute of Biomedical Research Asset Turnover Related Terms

Institute of Biomedical Research Asset Turnover Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research Asset Turnover Chart

Institute of Biomedical Research Annual Data
Trend Dec03 Dec04 Mar06 Mar07 Mar08 Mar09 Mar10
Asset Turnover
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Institute of Biomedical Research Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MRES vs HSTC, NTRR, VITIF: Asset Turnover Comparison

For the Biotechnology subindustry, Institute of Biomedical Research's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Institute of Biomedical Research Asset Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Institute of Biomedical Research's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Institute of Biomedical Research's Asset Turnover falls into.


Institute of Biomedical Research Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Institute of Biomedical Research's Asset Turnover for the fiscal year that ended in Mar. 2010 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2010 )/( (Total Assets (A: Mar. 2009 )+Total Assets (A: Mar. 2010 ))/ count )
=0/( (0.078+0.076)/ 2 )
=0/0.077
=0.00

Institute of Biomedical Research's Asset Turnover for the quarter that ended in Dec. 2010 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2010 )/( (Total Assets (Q: Sep. 2010 )+Total Assets (Q: Dec. 2010 ))/ count )
=0/( (0.668+0.655)/ 2 )
=0/0.6615
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.00 mean?
Institute of Biomedical Research (MRES) has a Asset Turnover of 0.00 as of Dec. 2010. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Institute of Biomedical Research and its competitors.
Is Institute of Biomedical Research's Asset Turnover too high?
Institute of Biomedical Research's current Asset Turnover is 0.00.
How does Institute of Biomedical Research's Asset Turnover compare to HSTC and NTRR?
Institute of Biomedical Research's Asset Turnover of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Biotechnology company?
A good Asset Turnover depends on the Biotechnology industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Institute of Biomedical Research and its competitors. Institute of Biomedical Research's current Asset Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Institute of Biomedical Research stock overvalued right now?
Institute of Biomedical Research (MRES) has a current Asset Turnover of 0.00. The current Asset Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Institute of Biomedical Research (MRES), the current Asset Turnover is 0.00 as of Dec. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Institute of Biomedical Research Business Description

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452
Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.